South Korean biopharmaceutical business of the Samyang group (formerly Samyang Genex), operating the Daejeon pharmaceutical plant for cytotoxic anticancer injectables such as Genexol paclitaxel, and producing absorbable sutures for customers in 45 countries.
Aucun commentaire disponible.
Laissez votre note & commentaire